In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying multiple copies of a viral CD8+ T-cell epitope

FEMS Immunology and Medical Microbiology

Volumn 26, Issue 2, 1999, Pages 167-173

  Šebo, Peter ^a   Moukrim, Zohra ^b   Kalhous, Miloš ^a   Schaft, Niels ^a   Dadaglio, Gilles ^b   Sheshko, Valeria ^a   Fayolle, Catherine ^b   Leclerc, Claude ^b  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b INSTITUT PASTEUR   (France)

Author keywords

Adenylate cyclase; Bordetella; Cytotoxic T cell response; Epitope delivery

Indexed keywords

ADENYLATE CYCLASE; CD8 ANTIGEN; EPITOPE; PERTUSSIS TOXIN; RECOMBINANT ENZYME; VIRUS VECTOR;

ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENYLATE CYCLASE TOXIN; ANIMALS; ANTIGENS, CD8; BORDETELLA PERTUSSIS; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; ESCHERICHIA COLI; FEMALE; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; T-LYMPHOCYTES; VACCINATION; VIRULENCE FACTORS, BORDETELLA;

EID: 0344931859     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00137-6     Document Type: Article

References (26)

1. Goletz T.J., Klimpel K.R., Arora N., Leppla S.H., Keith J.M., Berzofsky J.A. Targeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion protein. Proc. Natl. Acad. Sci. USA. 94:1997;12059-12064.
2. Goletz T.J., Klimpel K.R., Leppla S.H., Keith J.M., Berzofsky J.A. Delivery of antigens to the MHC class I pathway using bacterial toxins. Hum. Immunol. 54:1997;129-136.
3. Liu M.A. The immunologist's grail: vaccines that generate cellular immunity. Proc. Natl. Acad. Sci. USA. 94:1997;10496-10498.
4. Wolff J., Cook G.H., Goldhammer A.R., Berkowitz S.A. Calmodulin activates prokaryotic adenylate cyclase. Proc. Natl. Acad. Sci. USA. 77:1980;3841-3844.
5. Confer D.L., Eaton J.W. Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science. 217:1982;948-950.
6. Hewlett E.L., Smith D.L., Myers G.A., Pearson R.D., Kay H.D. In vitro inhibition of human natural killer (NK) cell cytotoxicity by Bordetella cyclase and pertussis toxin. Clin. Res. 31:1983;365A.
7. Hanski E. Invasive adenylate cyclase toxin of Bordetella pertussis. Trends Biochem. Sci. 14:1989;459-463.
8. Glaser P., Ladant D., Sezer O., Pichot F., Ullmann A., Danchin A. The calmodulin-sensitive adenylate cyclase of Bordetella pertussis: cloning and expression in Escherichia coli. Mol. Microbiol. 2:1988;19-30.
9. Glaser P., Sakamoto H., Bellalou J., Ullmann A., Danchin A. Secretion of cyclolysin, the calmodulin-sensitive adenylate cyclase-haemolysin bifunctional protein of Bordetella pertussis. EMBO J. 7:1988;3997-4004.
10. Weiss A.A., Hewlett E.L. Virulence factors of Bordetella pertussis. Annu. Rev. Microbiol. 40:1986;661-686.
11. Gordon V.M., Young W.W. Jr., Lechler S.M., Gray M.C., Leppla S.H., Hewlett E.L. Adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis. Different processes for interaction with and entry into target cells. J. Biol. Chem. 264:1989;14792-14796.
12. Hanski E., Farfel Z. Bordetella pertussis invasive adenylate cyclase: partial resolution and properties of its cellular penetration. J. Biol. Chem. 260:1985;5526-5532.
13. + T cell epitopes. J. Immunol. 156:1996;4697-4706.
14. Iwaki M., Ullmann A., Šebo P. Identification by in vitro complementation of regions required for cell-invasive activity of Bordetella pertussis adenylate cyclase toxin. Mol. Microbiol. 17:1995;1015-1024.
15. Fayolle C., Ladant D., Karimova G., Ullmann A., Leclerc C. Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase toxins carrying a cytotoxic T-cell epitope. J. Immunol. 162:1999;4157-4162.
16. + T cell epitope from lymphocytic choriomeningitis virus. Proc. Natl. Acad. Sci. USA. 94:1997;3314-3319.
17. Šebo P., Fayolle C., d'Andria O., Ladant D., Leclerc C., Ullmann A. Cell-invasive activity of epitope-tagged adenylate cyclase of Bordetella pertussis allows in vitro presentation of a foreign epitope to CD8+ cytotoxic T cells. Infect. Immun. 63:1995;3851-3857.
18. Hormozi K., Parton R., Coote J. Adjuvant and protective properties of native and recombinant Bordetella pertussis adenylate cyclase toxin preparations in mice. FEMS Immunol. Med. Microbiol. 23:1999;273-282.
19. Hedegaard L., Danchin A. The cya gene region of Erwinia chrysanthemi B374: organization and gene products. Mol. Gen. Genet. 201:1985;38-42.
20. Ladant D., Glaser P., Ullmann A. Insertional mutagenesis of Bordetella pertussis adenylate cyclase. J. Biol. Chem. 267:1992;2244-2250.
21. Betsou F., Šebo P., Guiso N. CyaC-mediated activation is important not only for toxic but also for protective activities of Bordetella pertussis adenylate cyclase- hemolysin. Infect. Immun. 61:1993;3583-3589.
22. Šebo P., Glaser P., Sakamoto H., Ullmann A. High-level synthesis of active adenylate cyclase toxin of Bordetella pertussis in a reconstructed Escherichia coli system. Gene. 104:1991;19-24.
23. Sakamoto H., Bellalou J., Šebo P., Ladant D. Bordetella pertussis adenylate cyclase toxin. Structural and functional independence of the catalytic and hemolytic activities. J. Biol. Chem. 267:1992;13598-13602.
24. Basar T., Havlíček V., Bezoušková S., Halada P., Hackett M., Šebo P. The conserved lysine 860 in the additional fatty-acylation site of Bordetella pertussis adenylate cyclase toxin is crucial for toxin function independently of its acylation status. J. Biol. Chem. 274:1999;10777-10783.
25. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
26. Bellalou J., Sakamoto H., Ladant D., Geoffroy C., Ullmann A. Deletions affecting hemolytic and toxin activities of Bordetella pertussis adenylate cyclase. Infect. Immun. 58:1990;3242-3247.